Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer
Clinical trial NCT02810743 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02810743
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-25
- Primary completion
- 2024-07-18
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.